A peer-reviewed analysis of recent backroom political spending suggests that regular, moderate doses of industry schmoozing may be highly efficacious in preventing public health limits. However, experts caution that the observational data is still early.
A peer-reviewed analysis of recent backroom political spending suggests that regular, moderate doses of alcohol industry lobbying may be highly efficacious in preventing federal regulation. However, experts caution that the observational data is still early, and more research is needed to definitively prove that handing lawmakers millions of dollars directly causes them to vote against public health limits.
Faced with a statistically significant decline in consumer demand, major trade groups including the Distilled Spirits Council have reportedly initiated a vigorous regimen of behind-the-scenes influence. While early results show the industry successfully beating back proposed warning labels and tax increases, researchers warn that confounding variables—such as politicians simply enjoying the taste of deregulation—make it difficult to establish a clear causal link.
We are seeing a robust association between sustained exposure to beverage lobbyists and a sudden, acute relaxation of public health guidelines, but we must be careful not to jump to conclusions.
The cohort of industry operatives utilized a novel protocol of targeted campaign contributions and private dinners to combat what they diagnosed as an alarming, systemic drop in alcohol sales. Though the intervention appears to be successfully reversing the adverse effects of recent World Health Organization guidance on the dangers of drinking, the authors of the study note that the sample size of compliant senators is relatively small, and the data on their sudden change of heart is largely self-reported.
For now, federal health agencies advise the public to interpret the sudden legislative victories of the alcohol sector with a degree of healthy skepticism. Until a randomized, double-blind clinical trial of Congress can be safely conducted, the CDC recommends assuming that the ongoing rollback of alcohol restrictions may carry severe, long-term side effects for anyone not currently serving on a corporate board.